PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
John Samuel |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
2,000,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Alan Miller |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
1,000,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Antony Odell |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
150,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Jonathan Glenn |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
600,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Paul Devlin |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
300,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Steven Couldwell |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
300,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |
PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Shervanthi Homer Vanniasinkam |
2 |
Reason for the notification |
a) |
Position/status |
Director |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Tissue Regenix Group plc |
b) |
LEI |
213800PNOD5UHQUFJI36 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each |
|
GB00B5SGVL29
|
b) |
Nature of the transaction |
Subscription for ordinary shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
10 pence per ordinary share |
250,000 |
|
d) |
Aggregated information
|
N/A |
e) |
Date of the transaction |
9 August 2017 |
f) |
Place of the transaction |
Outside a trading venue |